نتایج جستجو برای: شرکت novartis

تعداد نتایج: 53699  

Journal: :JAMA 2009
M Sirajul Islam Stanley M Midzi Lincoln Charimari Alejandro Cravioto Hubert P Endtz

Financial Disclosures: Dr Lyketsos reported having received grant support from the National Institute of Mental Health, the National Institute on Aging, the Associated Jewish Federation of Baltimore, the Weinberg Foundation, Forest, GlaxoSmithKline, Eisai, Pfizer, AstraZeneca, Lilly, Ortho-McNeil, Bristol-Myers, and Novartis; having served as a consultant or advisor for AstraZeneca, GlaxoSmithK...

Journal: :JAMA dermatology 2013
Akane Minagawa Hiroshi Koga Hisashi Uhara Yoshiharu Yokokawa Ryuhei Okuyama

Conflict of Interest Disclosures:DrWinthrop has received a research grant from Pfizer and scientific advisory board or consultant fees from Amgen, Abbott, Genentech, and Pfizer. Dr Blauvelt has received scientific advisory board and consulting fees from Janssen, Abbott, Amgen, Novartis, Pfizer, Anacor, Takeda, and Boehringer Ingelheim. Dr Deodhar has received research grants from Amgen, Genente...

2011
Hebert Echenique-Rivera Brunella Brunelli Maria Scarselli Anna Rita Taddei Beatrice Aricò Davide Serruto

7 1 Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy 8 2 Centro Interdipartimentale di Microscopia Elettronica, University of Tuscia, 01100 Viterbo, 9 Italy. 10 11 12 Running Title: Natural mutation in the translocator domain of NhhA 13 14 * Corresponding author: Beatrice Aricò, Novartis Vaccines and Diagnostics 15 Via Fiorentina, 1 16 53100 Siena, Italy 17 Tel: +39 0577 ...

2016

Nanotechnology is widely anticipated as one of the key technologies of the 21st century. As an enabling technology, it does and will increasingly impact other technologies but also products including innovative diagnostic tools and medicines. Novartis is aware that, as for any technology, benefits and risks of nanotechnology have to be evaluated and shares consumers' and patients' interest in i...

2015
Mario Castro Ratko Djukanovic Michael Wechsler

Disclosure: Mario Castro has received research support from NIH, ALA, CDC, Amgen, Boston Scientific, Boehringer Ingelheim, Cephalon, Genentech, GSK, Invion, Johnson & Johnson, Kalobios, MedImmune, NextBio, Novartis, Sanofi Aventis, and Vectura. He is on the lecture bureau for Boehringer Ingelheim, Boston Scientific, Genentech, GSK, and Teva. He has acted as consultant for Boston Scientific, Gal...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید